BioSpace News Archive

Tonix Pharmaceuticals Holding Corp. will present and conduct investor meetings at NobleCon18, Noble Capital Markets’ Eighteenth Annual In-Person Small & Microcap Investor Conference being held April 19-21, 2022, in Hollywood, Florida.

XORTX Therapeutics Inc., a pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce receipt of a no objection letter from Health Canada regarding the Company’s upcoming XRX-OXY-101 clinical bridging pharmacokinetics study.

PharmaTher Holdings Ltd. is pleased to announce that PharmaTher has entered into an exclusive worldwide license agreement with Gesval S.A., a public limited company incorporated by the University of Liège, Belgium, for the development and commercialization of a patented continuous-flow process technology for the preparation of ketamine and ketamine analogs.

Cyclacel Pharmaceuticals, Inc. today announced a publication in the journal Leukemia.

Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced the launch of the Simple Plex™ HEK 293 HCP 3G assay for automated process impurity testing on the Ella™ immunoassay platform.

The computed tomography market has been anticipated to experience numerous growth opportunities in the foreseeable years.

Biopsy punch is the technique to remove the round core from the center of a specified area of skin.

The advanced drug delivery market has been projected to grow at a rapid pace in the foreseeable years.

The isothermal nucleic acid amplification technology/INAAT market has been estimated to experience numerous growth opportunities in the following years.

Albany NY, United States: Urologic diseases are chronic conditions of the prostate gland, kidneys, urinary tract, and bladder.